Advertisement

Collagen Vascular Diseases

  • Joseph P. LynchIII
  • Jonathan B. Orens
  • Ella Kazerooni
Chapter

Abstract

Pleuropulmonary complications of collagen vascular disorders (CVDs) are protean, and include: pleuritis, pleural effusions, bronchiolitis obliterans (with or without organizing pneumonia), small airways disease, chronic interstitial pneumonitis/fibrosis, pulmonary hemorrhage, vasculitis, pulmonary hypertension, nodules, diaphragmatic weakness, and opportunistic infections or pulmonary toxicity due to immunosuppressive drug therapy [1–7] (Table 16.1). Given the emphasis of this book on diffuse lung disorders, we primarily focus on chronic interstitial lung disease (CILD), which may complicate any of the CVDs. We briefly allude to additional complications which are of special importance for some of the CVDs.

Keywords

Pulmonary Hypertension Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Systemic Sclerosis Lung Biopsy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wiedemann HP, Matthay RA (1989) Pulmonary manifestations of the collagen vascular diseases Clin Chest Med 10: 677–722.Google Scholar
  2. 2.
    Todd NW, Wise RA (1996) Respiratory complications in the collagen vascular diseases. Clin Pulm Med 3: 101–112.CrossRefGoogle Scholar
  3. 3.
    Wise RA (1991) Pulmonary complications in collagen vascular disease. In: Lynch J., III., DeRemee R., Immunologically mediated pulmonary disorders. JB Lippincott, Phila, PA, pp. 40–88.Google Scholar
  4. 4.
    Hunninghake GW, Fauci AS (1979) Pulmonary involvement in the collagen vascular diseases Am Rev Resp Dis 119: 471–503.Google Scholar
  5. 5.
    Joseph J, Sahn SA (1993) Connective tissue diseases and the pleura. Chest 104: 262–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Toews GB, Lynch JP III (1990) Pathogenesis and clinical features of pulmonary infections in patients with rheumatic disease. In: Cannon G., Zimmerman G., The Lung in Rheumatic Diseases. Marcel Dekker, Inc. New York, Vol. 45, pp. 179–226.Google Scholar
  7. 7.
    Martinez F, Lynch JP, III (1994) Collagen vascular disease-associated bronchiolitis obliterans organizing pneumonia. In: Epler G., eds. Diseases of the bronchioles. Raven Press, New York, pp. 347–66.Google Scholar
  8. 8.
    Lynch JP, III, Hunninghake GW (1992) Pulmonary complications of collagen vascular disease. Annu Rev Med 43: 17–35.PubMedCrossRefGoogle Scholar
  9. 9.
    Agusti C, Xaubet A, Roca J et al. (1992) Interstitial pulmonary fibrosis with and without associated col-lagen vascular disease: results of a two year follow up. Thorax 47: 1035–40.PubMedCrossRefGoogle Scholar
  10. 10.
    Wallaert B, Dugas M, Dansin E et al. (1990) Subclinical alveolitis in immunological disorders. Transition between health and disease? Eur Respir J 8: 1206–16.Google Scholar
  11. 11.
    Tazelaar HD, Viggiano RW, Pickersgill J et al. (1990) Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings Am Rev Respir Dis 141: 727–33.Google Scholar
  12. 12.
    Yousem SA, Colby TV, Carrington CB (1985) Lung biopsy in rheumatoid arthritis Am Rev Respir Dis 131: 770–7.Google Scholar
  13. 13.
    Lynch JP, III, McCune WJ (1997) Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders: State of The Art. Am J Respir Crit Care Med 155: 395–420.PubMedGoogle Scholar
  14. 14.
    Grubben MJ, Kerstens PJ, Wiersma JM et al. (1993) Pleuro-pulmonary involvement in patients with connective tissue disease. The role of open lung biopsy. Neth J Med 43: 269–76.PubMedGoogle Scholar
  15. 15.
    Wallaert B, Hatron PY, Grossbois JM et al. (1986) Subclinical pulmonary involvement in collagen vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 133: 574–80.PubMedGoogle Scholar
  16. 16.
    Remy-Jardin M, Remy J, Wallaert B et al. (1993) Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage Radiology 188: 499–506.Google Scholar
  17. 17.
    Silver RM, Miller KS (1990) Lung involvement in systemic sclerosis Rheumatic Dis Clin N America 16: 199–216.Google Scholar
  18. 18.
    Gabbay E, Tarala R, Will R et al. (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156: 528–35.PubMedGoogle Scholar
  19. 19.
    Wallaert B, Prin L, Hatron PY et al. (1987) Lymphocyte subpopulations in bronchoalveolar lavage in Sjogren’s syndrome: Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neu trophilia Chest 92: 1025–31.Google Scholar
  20. 20.
    Rossi GA, Bitterman PB, Rennard SI et al. (1985) Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis Am Rev Respir Dis 131: 612–17.Google Scholar
  21. 21.
    Harrison NK, Glanville AR, Strickland B et al. (1989) Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance Respir Med 83: 403–14.Google Scholar
  22. 22.
    Remy-Jardin M, Remy J, Cortet B et al. (1994) Lung changes in rheumatoid arthritis: CT findings. Radiology 193: 375–82.PubMedGoogle Scholar
  23. 23.
    McDonagh J, Greaves M, Wright AR et al. (1994) High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 33: 118–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Fujii M, Adachi S, Shimizu T (1993) Interstitial lung disease in rheumatoid arthritis: assessment with high resolution computed tomography. J Thorac Imaging 8: 54–62.PubMedGoogle Scholar
  25. 25.
    Johkoh T, Ikezoe J, Kohno N (1994) High-resolution CT and pulmonary function tests in vollagen vascular disease: comparison with idiopathic pulmonary fibrosis. Eur J Radiol 18: 113–121.PubMedCrossRefGoogle Scholar
  26. 26.
    Wells AU, Hansell DM, Corrin B et al. (1992) High- resolution computed tomography as a predictor of lung histology in systemic sclerosis Thorax 47: 738–42.Google Scholar
  27. 27.
    Wells AU, Cullinan P, Hansell DM et al. (1994) Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis Am J Respir Crit Care Med 149: 1583–9.Google Scholar
  28. 28.
    Seibold JR (1997) Scleroderma. In: Kelley W., Harris E., Jr., Ruddy S., Sledge G., eds. Textbook of rheumatology. WB Saunders Co. Philadelphia, PA, pp. 1133–62.Google Scholar
  29. 29.
    Wells AU, Hansell DM, Rubens MB et al. (1997) Functional impairment in long cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis. A comparison. Am J Resp Dis 155: 1657–64.Google Scholar
  30. 30.
    Bulpitt KJ, Clements PJ, Lachenbruch PA (1993) Early undifferentiated connective tissue disease. III. Outcome and prognostic indicators in early sclero-derma (systemic sclerosis). Ann Intern Med 118: 602–9.PubMedGoogle Scholar
  31. 31.
    Arroliga AC, Podell DN, Matthay RA (1992) Pulmonary manifestations of scleroderma. J Thorac Imaging 7: 30–45.PubMedCrossRefGoogle Scholar
  32. 32.
    Bolster MB, Silver RM (1996) Therapy of scleroderma lung disease. Clin Pulm Med 3: 314–22.CrossRefGoogle Scholar
  33. 33.
    Battle RW, Davitt MA, Cooper SM et al. (1996) Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 110: 1515–19.PubMedCrossRefGoogle Scholar
  34. 34.
    Koh ET, Lee P, Gladman DD et al. (1996) Pulmonary hypertension in systemic sclerosis: an alalysis of 17 patients. Br J Rheumatol 35: 989–93.PubMedCrossRefGoogle Scholar
  35. 35.
    Yousem SA (1990) The pulmonary pathologic manifestations of the CREST syndrome Hum Pathol 21: 467–74.Google Scholar
  36. 36.
    Wells AU, Hansell DH, Rubens MB et al. (1994) Fibrosing alveolitis in systemic sclerosis: bron- choalveolar lavage findings in relation to computed tomographic appearance Am J Respir Crit Care Med 150: 462–8.Google Scholar
  37. 37.
    Harrison MK, Myers R, Corrin B et al. (1991) Structural features of interstitial lung disease in sys-temic sclerosis Am Rev Respir Dis 144: 706–13.Google Scholar
  38. 38.
    Peters-Golden M, Wise RA, Hochberg MC et al. (1984) Carbon monoxide diffusing capacity as pre-dictor of outcome in systemic slcerosis Am J Med 77: 1027–34.Google Scholar
  39. 39.
    Greenwald GI, Tashkin DP, Gong H et al. (1987) Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis: prospecpective study. Am J Med 83: 83–91.PubMedCrossRefGoogle Scholar
  40. 40.
    Peters-Golden M, Wise RA, Schneider P et al. (1984) Clinical and demographic predictors of loss of pul-monary function in systemic sclerosis Medicine 63: 221–31.Google Scholar
  41. 41.
    Steen VD, Graham G, Conta C (1992) Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 35: 755–70.CrossRefGoogle Scholar
  42. 42.
    Schurawitzki H, Stiglbauer R, Graninger W (1990) Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography Radiology 176: 755–9.Google Scholar
  43. 43.
    Wells A, DuBois R (1993) Bronchiolitis in association with connective tissue disorders Clin in Chest Med 14: 655–66.Google Scholar
  44. 44.
    Wells AU, Hansell DM, Rubens MB et al. (1993) The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis Am Rev Respir Dis 148: 1076–82.Google Scholar
  45. 45.
    Chan TYK, Hansell DM, Rubens MB et al. (1997) Cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: morphological differences on computed tomographic scans. Thorac 52: 265–70.Google Scholar
  46. 46.
    Wechsler RJ, Steiner RM, Spirn PW (1996) The rela-tionship of thoracic lymphadenopathy to pulmonary interstitial disease in diffuse and limited systemic sclerosis: CT findings. AJR 167: 101–4.Google Scholar
  47. 47.
    Vallance D, Lynch JP, III, McCune WJ (1995) Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis Curr Opin Rheumatol 7: 174–82.Google Scholar
  48. 48.
    Manoussakis MN, Constantopoulos SH, Gharavi AE et al. (1987) Pulmonary involvement in systemic sclerosis. Association with anti-Scl 70 antibody and digital pitting Chest 92: 509–13.Google Scholar
  49. 49.
    Martin L, Pauls JD, Ryan JP et al. (1993) Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone. Ann Rheum Dis 52: 780–4.PubMedCrossRefGoogle Scholar
  50. 50.
    Steen VD, Lanz JK, Jr., Conte C et al. (1994) Severe restrictive lung disease in systemic sclerosis Arthritis Rheum 37: 1283–9.Google Scholar
  51. 51.
    Sato S, Ihn H, Kikuchi K et al. (1994) Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis Arthritis Rheum 37: 391–4.Google Scholar
  52. 52.
    Salojin KV, Le Tonqueze M, Saraux A et al. (1997) Antiendothelial cell antibodies: useful markers of systemic sclerosis. Am J Med 102: 178–85.PubMedCrossRefGoogle Scholar
  53. 53.
    Fanti S, Fabritiis, Aloisi D et al. (1994) Early pulmonary involvement in systemic sclerosis assessed by technetium 99m-DTPA clearance rate. J Nucl Med 35: 1933–6.PubMedGoogle Scholar
  54. 54.
    Silver RM, Miller KS, Kinsella MB et al. (1990) Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 88: 470–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Groen H, Wichers G, ter Borg EJ et al. (1990) Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud’s pneumenon with and without an underlying connective tissue disease Am J Med 89: 34–41.Google Scholar
  56. 56.
    Akesson A, Scheja A, Lundin A et al. (1994) Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 37: 729–735.PubMedCrossRefGoogle Scholar
  57. 57.
    deClerck LS, Dequeker J, Francz L et al. (1987) D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study Arthritis Rheum 30: 643–50.Google Scholar
  58. 58.
    Steen VD, Owens GR, Redmond C et al. (1985) The effect of D-penicillamine on pulmonary findings in systemic sclerosis Arthritis Rheum 28: 882–8.Google Scholar
  59. 59.
    Clements PJ, Lachenbruch PA, Sterz M et al. (1993) Cyclosporin in systemic sclerosis: results of a 48 week open safety study in 10 patients Arthritis Rheum 36: 75–83.Google Scholar
  60. 60.
    Fürst DE, Clements PJ, Hillis S et al. (1989) Immunosuppression with chlorambucil versus placebo for scleroderma. Results of a three-year, parallel, randomized, double-blind study Arthritis Rheum 32: 584–93.Google Scholar
  61. 61.
    Owens GR, Fino GJ, Herbert DL (1983) Pulmonary function in progressive systemic sclerosis: Comparison of CREST syndrome variant with diffuse scleroderma. Chest 84: 546–50.PubMedCrossRefGoogle Scholar
  62. 62.
    Murata I, Takenaka K, Yoshinoya S et al. (1997) Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 111: 36–43.PubMedCrossRefGoogle Scholar
  63. 63.
    Alpert MA, Pressly TA, Mukerji V (1991) Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome, and mixed connective tissue disease. Am J Cardiol 68: 1687–91.PubMedCrossRefGoogle Scholar
  64. 64.
    Alpert MA, Pressly TA, Mukerji V (1992) Short- and long-term hemodynamic effects of Captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest 102: 1407–12.PubMedCrossRefGoogle Scholar
  65. 65.
    Vergnenegre A, Pugnere N, Antoni MT et al. (1997) Airway obstruction and rheumatoid arthritis. Eur Respir J 10: 1077–86.CrossRefGoogle Scholar
  66. 66.
    Adams-Gandhi LB, Boyd AS, King LE (1996) Diagnosis and management of dermatomyositis Comprehensive Therapy 22: 156–64.Google Scholar
  67. 67.
    Dalakas MC (1991) Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 325: 1487–98.PubMedCrossRefGoogle Scholar
  68. 68.
    Targoff IN (1994) Immune manifestations of inflammatory muscle disease. Rheum Dis Clin 20: 857–80.Google Scholar
  69. 69.
    Schwartz MI (1992) Pulmonary and cardiac manifestations of polymyositis/dermatomyositis. J Thorac Imaging 7: 46–54.CrossRefGoogle Scholar
  70. 70.
    Cronin ME, Plötz PH (1990) Idiopathic inflammatory myopathies. Rheum Dis Clin North Am 16: 655–65.PubMedGoogle Scholar
  71. 71.
    Lakhanapal S, Lie JT, Conn DL et al. (1987) Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 cases. Ann Rheum Dis 47: 23–9.CrossRefGoogle Scholar
  72. 72.
    Sharp GE, Irving W, Tan E et al. (1972) Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Am J Med 52: 148–59.PubMedGoogle Scholar
  73. 73.
    Sullivan WD, Hurst DJ, Harmon CE et al. (1984) A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease Medicine 63: 92–107.Google Scholar
  74. 74.
    Maccioni FJ, Colebatch HJ (1990) Management of fibrosing alveolitis with polymyositis/dermatomyositis. Aust NZ J Med 20: 806–10.CrossRefGoogle Scholar
  75. 75.
    Marguerie C, Bunn CC, Beynon H (1990) Polymyositis, pulmonary fibrosis, and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77: 1019–38.PubMedCrossRefGoogle Scholar
  76. 76.
    Arsura EL, Greenberg AS (1988) Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis Semin Arthritis Rheum 18: 29–37.Google Scholar
  77. 77.
    Targoff IN (1993) Humoral immunity in poly-myositis/dermatomyositis J Invest Dermatol 100: 116S–23S.CrossRefGoogle Scholar
  78. 78.
    Targoff IN, Arnett FA, Berman L et al. (1989) Anti- KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest 84: 162–72.PubMedCrossRefGoogle Scholar
  79. 79.
    Hacking JC, Flower CD (1995) Causes and investigation of increasing dyspnoea in rheumatoid arthritis. Ann Rheum Dis 54: 17–19.PubMedCrossRefGoogle Scholar
  80. 80.
    Anaya JM, Diethelm L, Ortiz LA et al. (1995) Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 24: 242–54.PubMedCrossRefGoogle Scholar
  81. 81.
    Roschmann RA, Rothenberg RJ (1987) Pulmonary fibrosis in rheumatoid arthritis: A review of clinical features and therapy Semin Arthritis Rheum 16: 174–85.Google Scholar
  82. 82.
    Helmers R, Galvin J, Hunninghake GW (1991) Pulmonary manifestations associated with rheumatoid arthritis. Chest 100: 235–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Geddes DM, Corrin B, Brewerton DA (1977) Progressive airway obliterantion in adults and its association with rheumatoid disease. Q J Med 46: 427–44.PubMedGoogle Scholar
  84. 84.
    Penny WJ, Knight RK, Rees Am (1982) Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis 41: 469–72.PubMedCrossRefGoogle Scholar
  85. 85.
    Hakala M, Paakko P, Huhti E (1990) Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 9: 452–60.PubMedCrossRefGoogle Scholar
  86. 86.
    Ippolito JA, Palmer L, Spector S (1993) Bronchiolitis obliterans ogranizing pneumonia and rheumatoid arthritis. Semin Arthritis Rheum 23: 70–8.PubMedCrossRefGoogle Scholar
  87. 87.
    van Thiel RJ, vander Burg S, Groote AD (1991) Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Eur Respir J 4: 905–11.PubMedGoogle Scholar
  88. 88.
    Hassan WU, Keaney NP, Holland CD et al. (1994) Bronchial hyperreactivity and airflow obstruction in rheumatoid arthritis. Ann Rheum Dis 53: 511–14.PubMedCrossRefGoogle Scholar
  89. 89.
    Begin R, Masses S, Cantin A (1982) Airway disease 4 in a subset of non-smoking rheumatoid patients: characterization of the disease and evidence of an autoimmune pathogenesis. Am J Med 72: 743–50.PubMedCrossRefGoogle Scholar
  90. 90.
    McMahon MJ, Swinson DR, Shettar S (1993) Bronchiectasis and rheumatoid arthritis: a clinical study. Ann Rheum Dis 52: 776–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Hillarby MC, McMahon MJ, Grennan DM (1993) HLA associations in subjects with rheumatoid arthritis and bronchiectasis but not with other pulmonary complications of rheumatoid disease. Br J Rheumatol 32: 794–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Shadick NA, Fanta CH, Weinblatt ME (1994) Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore); 73: 161–70.CrossRefGoogle Scholar
  93. 93.
    Young ID, Ford SE, Ford PM (1989) The association of pulmonary hypertension with rheumatoid arthritis. J Rheumatol 16: 1266–9.PubMedGoogle Scholar
  94. 94.
    Godeau B, Coutant-Perronne V, Huong DLT (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21: 246–51.PubMedGoogle Scholar
  95. 95.
    Zitnik RJ, Cooper JA Jr (1990) Pulmonary disease due to antirheumatic agents. Clin Chest Med 11: 139–54.PubMedGoogle Scholar
  96. 96.
    Hargraves MR, Mowat AG, Benson MK (1992) Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. Thorax 47: 628–33.CrossRefGoogle Scholar
  97. 97.
    Banks J, Banks C, Cheong B et al. (1992) An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med 307: 795–806.Google Scholar
  98. 98.
    Gilligan DM, O’Connor CM, Ward K et al. (1990) Bronchoalveolar lavage in patients with mild and severe rheumatoid lung disease. Thorax 45: 591–96.PubMedCrossRefGoogle Scholar
  99. 99.
    Garcia JG, James HL, Zinkgraft S et al. (1987) Lower respiratory tract abnormalities in rheumatoid inter-stitial lung disease. Potential role of neutrophils in lung injury Am Rev Respir Dis 136: 811–17.Google Scholar
  100. 100.
    Sato A, Hayakawa H, Uchiyama H et al. (1996) Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis. Am J Respir Crit Care Med 154: 1903–7.PubMedGoogle Scholar
  101. 101.
    Kolarz G, Scherak O, Popp W (1993) Bronchoalveolar lavage in rheumatoid arthritis. Br J Rheumatol 32: 556–61.PubMedCrossRefGoogle Scholar
  102. 102.
    Tishler M, Grief J, Fireman E (1986) Bronchoalveolar lavage: a sensitive test for early diagnosis of pul-monary involvement in rheumatoid arthritis J Rheumatol 13: 547–50.Google Scholar
  103. 103.
    Scherak O, Popp W, Kolarz G (1993) Bronchoalveolar lavage and lung biopsy in rheumatoid arthritis. In vivo effects of disease modifying antirheumatic drugs. J Rheumatol 20: 944–99.Google Scholar
  104. 104.
    Hassan WU, Keaney NP, Holland CD et al. (1995) Association of HLA-DR4, protease inhibitor phenotypes, and keratoconjunctivitis sicca with pulmonary abnormalities in rheumatoid arthritis. Br J Rheumatol 34: 37–40.PubMedCrossRefGoogle Scholar
  105. 105.
    Charles PJ, Sweatman MC, Markwick JR (1991) HLA-B40: a marker for susceptibility to lung disease in rheumatoid arthritis. Dis Markers 9: 97–101.PubMedGoogle Scholar
  106. 106.
    Popp W, Rauscher H, Ritschka L (1992) Prediction of interstitial lung involvement in rheumatoid arthritis: the value of clinical data, chest roentgenogram, lung function, and serologic parameters. Chest 102: 391–4.PubMedCrossRefGoogle Scholar
  107. 107.
    Pratt DS, Schwartz MI, May J J et al. (1979) Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax 34: 587–93.PubMedCrossRefGoogle Scholar
  108. 108.
    Hakala M (1988) Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 93: 114–18.PubMedCrossRefGoogle Scholar
  109. 109.
    Suzuki A, Ohosone Y, Obana M et al. (1994) Causes of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21: 33–6.PubMedGoogle Scholar
  110. 110.
    Carroll GJ, Thomas R, Phatouros CC et al. (1994) Incidence, prevalence, and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. J Rheumatol 21: 51–4.PubMedGoogle Scholar
  111. 111.
    Beyeler C, Jordi B, Gerber NJ et al. (1996) Pulmonary function in rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. Br J Rheumatol 35: 446–52.PubMedCrossRefGoogle Scholar
  112. 112.
    Hilliquin P, Rnoux M, Perrot S et al. (1996) Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 35: 441–5.PubMedCrossRefGoogle Scholar
  113. 113.
    LeDuc D, DeVuyst P, Lhereux PH (1993) Pneumonitis complicating low-dose methotrexate therapy for rheumatoid arthritis. Discrepancies between lung biopsy and bronchoalveolar lavage findings. Chest 104: 1620–3.PubMedCrossRefGoogle Scholar
  114. 114.
    Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271 -7.Google Scholar
  115. 115.
    Orens JB, Martinez FJ, Lynch JP, III (1994) Pleuropulmonary manifestations of systemic lupus erythematosus. In: McCune W., ed. Rheumatic disease clinics of North america. WB Saunders, Philadelphia, Vol. 20, pp. 159–93.Google Scholar
  116. 116.
    Matthay RA, Schwarz MI, Petty TL et al. (1974) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis Medicine 54: 397–409.Google Scholar
  117. 117.
    Laroche CM, Mulvey DA, Hawkins PN et al. (1989) Diaphragmatic strength in the shrinking lung syndrome of systemic lupus erythematosus Q J Med 71: 429–39.Google Scholar
  118. 118.
    Yoshio T, Masuyama JI, Sumiya M et al. (1994) Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythe-matosus. J Rheumatol 21: 2058–63.PubMedGoogle Scholar
  119. 119.
    Winslow TM, Ossipov MA, Fazio GP et al. (1995) Five year follow-up study of the prevalence and pro-gression of pulmonary hypertension in systemic lupus erythemstosus. Am Heart J 129: 510–15.PubMedCrossRefGoogle Scholar
  120. 120.
    Roncoroni AJ, Alvarez C, Molinas F (1992) Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration 59: 52–6.PubMedCrossRefGoogle Scholar
  121. 121.
    Alarcon-Segovia D, Deleze M, Oria CV et al. (1989) Antiphospholipid antibodies and the antiphospho- lipid syndrome in systemic lupus erythemotosus. A prospective analysis of 500 consecutive patients. Medicine 68: 353–65.PubMedGoogle Scholar
  122. 122.
    Zamora MR, Warner ML, Tuder R et al. (1997) Diffuse alveolar hemorrhage and systemic lupus erythematousus. Medicine 76: 192–202.PubMedCrossRefGoogle Scholar
  123. 123.
    Myers JL, Katzenstein AA (1985) Microangitis in lupus-induced pulmonary hemorrhage Am J Clin Pathol 85: 552–6.Google Scholar
  124. 124.
    Haupt HM, Moore GW, Hutchins GM (1981) The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients Am J Med 71: 791–8.Google Scholar
  125. 125.
    Hedgpeth MT, Boulware DW (1988) Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-ro (SS-A) antibodies Arthritis Rheum 31: 545–8.Google Scholar
  126. 126.
    Weinrib L, Sharma OP, Quismorio FP Jr (1990) A long-term study of interstitial lung disease in systemic lupus erythematosus Semin Arthritis Rheum 20: 48–56.Google Scholar
  127. 127.
    Andrononpoulos AP, Costantopoulos SH, Galanopoulou V et al. (1992) Pulmonary function in non-smoking patients with systemic lupus erythe-matosus. Chest 92: 312–15.Google Scholar
  128. 128.
    Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50: 85–94.PubMedCrossRefGoogle Scholar
  129. 129.
    Fenlon HM, Doran M, Sant SM etal. (1996) High-resolution chest CT in systemic lupus erythematosus. AJR 166: 301–7.Google Scholar
  130. 130.
    Groen H, ter Borg EJ, Postma DS et al. (1992) Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic and nail- fold capillary patterns Am J Med 93: 619–27.Google Scholar
  131. 131.
    Eiser AR, Shanies HM (1994) Treatment of lupus interstitial lung disease with intravenous cyclophosphamide. Arthritis Rheum 37: 428–31.PubMedCrossRefGoogle Scholar
  132. 132.
    Hanly JG, Hong C, Zayed E et al. (1995) Immuno-modulating effects of synchronised plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus. Lupus 4: 457–63.PubMedCrossRefGoogle Scholar
  133. 133.
    Clegg DO, Williams HJ, Singer JZ (1991) Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 18: 1340–3.PubMedGoogle Scholar
  134. 134.
    Bennett RM (1997) Mixed connective tissue disease and other overlap syndromes. WB Saunders, Co. Philadelphia, PA, 1065–78.Google Scholar
  135. 135.
    Alarcon GS, Williams GV, Singer JZ (1991) Early undifferentiated connective tissue disease. I Early clinical manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 18: 1332–9.PubMedGoogle Scholar
  136. 136.
    Citera G, Lazaro MA, Maldonado Cocco JA (1995) Mixed connective tissue disease: fact or fiction? Lupus 4: 255–7.PubMedCrossRefGoogle Scholar
  137. 137.
    van den Hoogen FH, Spronk PE, Boerbooms AM et al. (1994) Long-term follow-up of 46 patients with anti-(ul) snRNP antibodies Brit J Rheum 33: 1117–20.Google Scholar
  138. 138.
    Lazaro MA, Maldonado Cocco JA, Catoggio LJ et al. (1989) Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 68: 58–65.PubMedCrossRefGoogle Scholar
  139. 139.
    Nimelstein SH, Brody S, McShane D et al. (1980) Mixed connective tissue disease: a subsequent evalu-ation of the original 25 patients Medicine 59: 239–48.Google Scholar
  140. 140.
    Hench PK, Edington TS, Tam EM (1975) The evolv-ing clinical spectrum of mixed connective tissue disease Arthritis Rheum 18: 404–8.Google Scholar
  141. 141.
    Prakash UBS, Luthra HS, Divertie MB (1985) Intrathoracic manifestations in mixed connective tissue disease Mayo Clin Proc 60: 813–21.Google Scholar
  142. 142.
    Prakash UB (1992) Lungs in mixed connective tissue disease. J Thorac Imaging 7: 55–61.PubMedCrossRefGoogle Scholar
  143. 143.
    Jolliet P, Thorens JB, Chevrolet JC (1995) Pulmonary vascular reactivity in severe pulmonary hypertension associated with mixed connective tissue disease. Thorax 50: 96–7.PubMedCrossRefGoogle Scholar
  144. 144.
    Shinohara S, Murata I, Yamada H (1994) combined effects of diltiazem and oxygen in pulmonary hypertension of mixed connective tissue disease. J Rheumatol 21: 1763–1865.Google Scholar
  145. 145.
    Isenberg DA, Black C (1995) ABC of rheumatology. Raynaud’s phenomenon, scleroderma, and overlap syndromes. BMJ 310: 795–8.Google Scholar
  146. 146.
    Derderian SS, Tellis CJ, Abbrecht PH et al. (1985) Pulmonary invovement in mixed connective tissue disease Chest 88: 45–8.Google Scholar
  147. 147.
    Suzuki M, Shimizu K, Sakamoto K et al. (1996) Interstitial pneumonia associated with mixed con-nective tissue disease-marked improvement with azathioprine Jap J Thorac Dis 34: 101–5.Google Scholar
  148. 148.
    Moutsopoulos HM, Chused TM, Mann DL et al. (1980) Sjogren’s syndrome (sicca Syndrome): Current Issues Ann Int Med 92: 212–26.Google Scholar
  149. 149.
    Deheinzelin D, Capelozzi VL, Kairalla RA et al. (1996) Interstitial lung disease in primary Sjogren’s syndrome. Clinicopathological evaluation and response to treatment. Am J Respir Crit Care Med 154: 794–9.PubMedGoogle Scholar
  150. 150.
    Hansen LA, Prakash UB, Colby TV (1989) Pulmonary lymphoma in Sjogren’s syndrome. Mayo Clin Proc 64: 920–31.PubMedGoogle Scholar
  151. 151.
    Fox RI, Robinson CA, Curd JG et al. (1986) Sjogren’s syndrome proposed criteria for classification Arthritis Rheum 29: 577–84.Google Scholar
  152. 152.
    Fairfax A J, Haslam PL, Pavia D et al. (1981) Pulmonary disorders associated with Sjogren’s syn-drome Q J Med 50: 279–95.Google Scholar
  153. 153.
    Kelly C, Gardiner P, Pal B et al. (1991) Lung function in primary Sjogren’s syndrome: a cross sectional and longitudinal study thorax 46: 180–8.Google Scholar
  154. 154.
    Vitali C, Bombardieri S, Moutsopoulos HM (1993) Preliminary criteria for the classification of Sjorgren’s syndrome. Result of a prospective concerted action supported by the European community. Arthritis Rheum 36: 340–7.PubMedCrossRefGoogle Scholar
  155. 155.
    Asherson RA, Munsey F, Pambakian H et al. (1987) Sjogren’s syndrome and fibrosing alveolitis compli-cated by pulmonary lymphoma Ann Rheum Dis 46: 701–5.Google Scholar
  156. 156.
    Anderson LG, Talal N (1979) The spectrum of benign to malignant lymphoproliferation in Sjogren’s syndrome Clin Exp Immunol 9: 199–221.Google Scholar
  157. 157.
    Koss MK (1995) Pulmonary lymphoid disorders Sem Diag Pathol 12: 158–71.Google Scholar
  158. 158.
    Gardiner P, Ward C, Allison A et al. (1993) Pleuro- pulmonary abnormalities in primary Sjogren’s syndrome J Rheum 20: 831–7.Google Scholar
  159. 159.
    Hatron PY, Wallaert B, Gösset D et al. (1987) Subclinical lung inflammation in primary Sjogren’s syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease Arthritis Rheum 30: 1226–31.Google Scholar
  160. 160.
    Dalavanga YA, Constantopoulos SH, Galanopoulou V et al. (1991) Alveolitis correlates with clinical pul-monary involvement in primary Sjogren’s syndrome Chest 99: 1394–7.Google Scholar
  161. 161.
    Papathanasiou MP, Constantopoulos SH, Tsampoulas C et al. (1986) Reappraisal of respiratory abnormalities in primary and secondary Sjogren’s syndrome. A controlled study Chest 90: 370–4.Google Scholar
  162. 162.
    Alkhayer M, McCann BG, Harrison BD (1988) Lymphocytic interstitial pneumonitis in association with Sjogren’s syndrome Br J dis Chest 82: 305–9.Google Scholar
  163. 163.
    Lahdensuo A, Korpela M (1995) Pulmonary findings in patients with primary Sjogren’s syndrome Chest 108: 316–19.Google Scholar
  164. 164.
    Strimlan CV, Rosenow EC, III, Divertie MB et al. (1976) Pulmonary manifestatons of Sjogren’s syn-drome Chest 70: 354–61.Google Scholar
  165. 165.
    Constanopoulos SH, Papadimitriou CH, Moutsopoulos HM (1985) Respiratory manifestations in primary Sjogren’s syndrome. A clinical, functional, and histologic study Chest 88: 226–9.Google Scholar
  166. 166.
    Kadota J, Kusano S, Kawakami K et al. (1995) Usual interstitial pneumonia associated with primary Sjogren’s syndrome Chest 108: 1756–8.Google Scholar
  167. 167.
    Tsuzaka K, Akama H, Yamada H et al. (1993) Pulmonary pseudolymphoma presented with a mass lesion in a patient with primary Sjogren’s syndrome: Beneficial effect of intermittent intravenous cyclophosphamide Scand J Rheum 22: 90–3.Google Scholar

Copyright information

© Springer-Verlag London Limited 1999

Authors and Affiliations

  • Joseph P. LynchIII
  • Jonathan B. Orens
  • Ella Kazerooni

There are no affiliations available

Personalised recommendations